MMedication Read More Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors sayMay 21, 2026 By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
MMedication Read More Could Eli Lilly’s Next Weight Loss Drug Waylay Wegovy — and Even Zap Zepbound?May 17, 2026 After losing its market edge to Eli Lilly (NYSE: LLY) despite its first-mover advantage in weight-loss drugs, Novo…
HHealthcare Read More Best Healthcare Stocks to Buy in 2026May 15, 2026 Biogen (NASDAQ: BIIB) and Novo Nordisk (NYSE: NVO) represent different opportunities within the healthcare sector: One is a…
MMedication Read More Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026May 14, 2026 Novo Nordisk A/S Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders…
MMedication Read More Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early respondersMay 14, 2026 Novo Nordisk has shared new data that suggests a higher dose version of its blockbuster weight loss drug,…
MMedication Read More Scoring 2 Million Prescriptions, Novo’s GLP-1 Pill Crushes ExpectationsMay 8, 2026 Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built…
MMedication Read More Oral Ozempic US Launch And Partnerships Test Novo Nordisk ValuationMay 4, 2026 Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
MMedication Read More Novo Nordisk Expands GLP-1 Reach With Oral Ozempic And Pediatric PushMay 2, 2026 Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
MMedication Read More Can Oral Ozempic and Label Expansions Revive NVO’s Near-Term Growth?April 29, 2026 Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic…
HHealthcare Read More Which Healthcare Giant Is the Better Bet?April 27, 2026 Novo Nordisk NVO and Pfizer PFE are both pharmaceutical giants based in Denmark and the United States, respectively, with…
MMedication Read More Lilly’s Foundayo hits 1,390 prescriptions in debut weekApril 17, 2026 April 17 (Reuters) – Eli Lilly’s newly launched obesity pill was prescribed 1,390 times in the U.S. as…
HHealthcare Read More Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker?April 11, 2026 Picking winning stocks could lead your portfolio into millionaire territory over time — so it’s important to choose…